vs

Side-by-side financial comparison of Lam Research (LRCX) and Welltower (WELL). Click either name above to swap in a different company.

Lam Research is the larger business by last-quarter revenue ($5.8B vs $2.8B, roughly 2.1× Welltower). Welltower runs the higher net margin — 51.6% vs 31.2%, a 20.3% gap on every dollar of revenue. On growth, Welltower posted the faster year-over-year revenue change (180.6% vs 23.8%). Over the past eight quarters, Welltower's revenue compounded faster (42.4% CAGR vs 22.8%).

Lam Research Corporation is an American supplier of wafer-fabrication equipment and related services to the semiconductor industry. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices and their wiring (interconnects). The company also builds equipment for back-end wafer-level packaging (WLP) and for related manufacturing markets such as for microelectromechanical systems (MEMS).

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure. As of December 31, 2022, the company had investments in approximately 3,000 properties, all of which were in the United States, Canada, and the United Kingdom.

LRCX vs WELL — Head-to-Head

Bigger by revenue
LRCX
LRCX
2.1× larger
LRCX
$5.8B
$2.8B
WELL
Growing faster (revenue YoY)
WELL
WELL
+156.8% gap
WELL
180.6%
23.8%
LRCX
Higher net margin
WELL
WELL
20.3% more per $
WELL
51.6%
31.2%
LRCX
Faster 2-yr revenue CAGR
WELL
WELL
Annualised
WELL
42.4%
22.8%
LRCX

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
LRCX
LRCX
WELL
WELL
Revenue
$5.8B
$2.8B
Net Profit
$1.8B
$1.5B
Gross Margin
49.8%
Operating Margin
35.0%
Net Margin
31.2%
51.6%
Revenue YoY
23.8%
180.6%
Net Profit YoY
37.2%
93.7%
EPS (diluted)
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LRCX
LRCX
WELL
WELL
Q1 26
$5.8B
$2.8B
Q4 25
$5.3B
$2.6B
Q3 25
$5.3B
$2.1B
Q2 25
$5.2B
$2.0B
Q1 25
$4.7B
$1.9B
Q4 24
$4.4B
$1.8B
Q3 24
$4.2B
$1.5B
Q2 24
$3.9B
$1.4B
Net Profit
LRCX
LRCX
WELL
WELL
Q1 26
$1.8B
$1.5B
Q4 25
$1.6B
$117.8M
Q3 25
$1.6B
$282.2M
Q2 25
$1.7B
$304.6M
Q1 25
$1.3B
$257.3M
Q4 24
$1.2B
$123.8M
Q3 24
$1.1B
$456.8M
Q2 24
$1.0B
$260.7M
Gross Margin
LRCX
LRCX
WELL
WELL
Q1 26
49.8%
Q4 25
49.6%
24.3%
Q3 25
50.4%
23.5%
Q2 25
50.1%
23.2%
Q1 25
49.0%
21.6%
Q4 24
47.4%
20.0%
Q3 24
48.0%
19.8%
Q2 24
47.5%
20.2%
Operating Margin
LRCX
LRCX
WELL
WELL
Q1 26
35.0%
Q4 25
33.9%
Q3 25
34.4%
14.2%
Q2 25
33.7%
15.1%
Q1 25
33.1%
10.7%
Q4 24
30.5%
6.2%
Q3 24
30.3%
12.2%
Q2 24
29.1%
6.5%
Net Margin
LRCX
LRCX
WELL
WELL
Q1 26
31.2%
51.6%
Q4 25
29.8%
4.6%
Q3 25
29.5%
13.7%
Q2 25
33.3%
15.5%
Q1 25
28.2%
13.8%
Q4 24
27.2%
7.0%
Q3 24
26.8%
30.2%
Q2 24
26.4%
18.7%
EPS (diluted)
LRCX
LRCX
WELL
WELL
Q1 26
$1.45
Q4 25
$1.26
$0.13
Q3 25
$1.24
$0.41
Q2 25
$1.34
$0.45
Q1 25
$1.03
$0.40
Q4 24
$0.92
$0.20
Q3 24
$0.86
$0.73
Q2 24
$7.78
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LRCX
LRCX
WELL
WELL
Cash + ST InvestmentsLiquidity on hand
$4.8B
Total DebtLower is stronger
Stockholders' EquityBook value
Total Assets
$20.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LRCX
LRCX
WELL
WELL
Q1 26
$4.8B
Q4 25
$6.2B
$5.0B
Q3 25
$6.7B
$6.8B
Q2 25
$6.4B
$4.4B
Q1 25
$5.5B
$3.5B
Q4 24
$5.7B
$3.5B
Q3 24
$6.1B
$3.6B
Q2 24
$5.8B
$2.8B
Total Debt
LRCX
LRCX
WELL
WELL
Q1 26
Q4 25
$3.7B
$19.2B
Q3 25
$3.7B
$16.9B
Q2 25
$3.7B
$16.0B
Q1 25
$3.7B
$15.7B
Q4 24
$4.5B
$15.5B
Q3 24
$4.5B
$15.8B
Q2 24
$4.5B
$13.9B
Stockholders' Equity
LRCX
LRCX
WELL
WELL
Q1 26
Q4 25
$10.1B
$42.1B
Q3 25
$10.2B
$38.8B
Q2 25
$9.9B
$35.9B
Q1 25
$9.5B
$34.0B
Q4 24
$8.8B
$32.0B
Q3 24
$8.5B
$30.3B
Q2 24
$8.5B
$29.0B
Total Assets
LRCX
LRCX
WELL
WELL
Q1 26
$20.8B
Q4 25
$21.4B
$67.3B
Q3 25
$21.9B
$59.5B
Q2 25
$21.3B
$55.8B
Q1 25
$20.0B
$53.3B
Q4 24
$19.8B
$51.0B
Q3 24
$19.5B
$49.0B
Q2 24
$18.7B
$45.5B
Debt / Equity
LRCX
LRCX
WELL
WELL
Q1 26
Q4 25
0.37×
0.46×
Q3 25
0.37×
0.43×
Q2 25
0.38×
0.44×
Q1 25
0.39×
0.46×
Q4 24
0.51×
0.49×
Q3 24
0.53×
0.52×
Q2 24
0.52×
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LRCX
LRCX
WELL
WELL
Operating Cash FlowLast quarter
$1.1B
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
0.63×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LRCX
LRCX
WELL
WELL
Q1 26
$1.1B
Q4 25
$1.5B
$654.3M
Q3 25
$1.8B
$858.4M
Q2 25
$2.6B
$770.0M
Q1 25
$1.3B
$599.0M
Q4 24
$741.9M
$559.2M
Q3 24
$1.6B
$685.0M
Q2 24
$862.4M
$605.4M
Free Cash Flow
LRCX
LRCX
WELL
WELL
Q1 26
Q4 25
$1.2B
$340.4M
Q3 25
$1.6B
$595.3M
Q2 25
$2.4B
$537.2M
Q1 25
$1.0B
$358.6M
Q4 24
$553.6M
$240.4M
Q3 24
$1.5B
$443.8M
Q2 24
$761.7M
$440.3M
FCF Margin
LRCX
LRCX
WELL
WELL
Q1 26
Q4 25
22.8%
13.3%
Q3 25
29.9%
28.9%
Q2 25
46.1%
27.3%
Q1 25
21.6%
19.2%
Q4 24
12.7%
13.6%
Q3 24
35.0%
29.4%
Q2 24
19.7%
31.6%
Capex Intensity
LRCX
LRCX
WELL
WELL
Q1 26
5.7%
Q4 25
4.9%
12.3%
Q3 25
3.5%
12.8%
Q2 25
3.3%
11.8%
Q1 25
6.1%
12.9%
Q4 24
4.3%
18.1%
Q3 24
2.7%
16.0%
Q2 24
2.6%
11.8%
Cash Conversion
LRCX
LRCX
WELL
WELL
Q1 26
0.63×
Q4 25
0.93×
5.56×
Q3 25
1.13×
3.04×
Q2 25
1.48×
2.53×
Q1 25
0.98×
2.33×
Q4 24
0.62×
4.52×
Q3 24
1.40×
1.50×
Q2 24
0.85×
2.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LRCX
LRCX

Segment breakdown not available.

WELL
WELL

Resident fees and services$1.9B67%
Other$822.6M29%
Rental income$103.4M4%

Related Comparisons